Checkpoint Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	16.88	16.39	36.5	54.43	62.09
Short-Term Investments	257.61	278.1	-	-	-
Cash & Short-Term Investments	274.49	294.48	36.5	54.43	62.09
Cash Growth	1915.51%	706.71%	-32.93%	-12.34%	-
Accounts Receivable	31.1	22.19	21.7	17.89	14.86
Other Receivables	-	15.66	12.75	9.07	0.81
Receivables	31.1	38.02	34.72	27.25	15.72
Inventory	4.25	2.83	2.15	1.99	1.65
Prepaid Expenses	4.6	3.3	3.56	2.24	1.5
Other Current Assets	-	-	-	0.56	0.56
Total Current Assets	314.45	338.63	76.94	86.46	81.52
Property, Plant & Equipment	207.18	181.43	168.43	85.69	67.55
Goodwill	9.19	1.36	1.28	0.78	0.78
Other Intangible Assets	9.96	9.23	13.93	14.63	5.72
Long-Term Accounts Receivable	137.56	114.61	59.33	57.54	48.87
Long-Term Deferred Tax Assets	16.63	16.28	4.24	2.73	5.55
Total Assets	694.97	661.8	324.51	248.43	210.38
Accounts Payable	30.2	12.64	14	12.95	5.45
Accrued Expenses	-	9.51	8.35	3.52	5.46
Current Portion of Long-Term Debt	-	-	-	3.36	0.49
Current Portion of Leases	19.69	22.2	20.17	16.81	15.39
Current Income Taxes Payable	4.7	10.14	3.64	-	0.54
Current Unearned Revenue	1.4	2.05	1.68	1.35	1.29
Other Current Liabilities	9.73	27.75	18.64	15.06	11.11
Total Current Liabilities	65.71	84.29	66.47	53.05	39.72
Long-Term Debt	-	-	3	-	3.36
Long-Term Leases	254.45	217.3	161.55	109.76	96.71
Long-Term Unearned Revenue	2.52	2.43	2.18	1.9	2.08
Other Long-Term Liabilities	4.66	3.81	3.35	2.61	2.19
Total Liabilities	327.34	307.82	236.54	167.33	144.06
Common Stock	373.59	372.71	104.05	99.16	90.26
Retained Earnings	-28.85	-36.15	-26.86	-24.59	-28.5
Comprehensive Income & Other	22.89	17.42	10.78	6.53	4.57
Shareholders' Equity	367.63	353.98	87.97	81.1	66.32
Total Liabilities & Equity	694.97	661.8	324.51	248.43	210.38
Total Debt	274.14	239.5	184.72	129.93	115.94
Net Cash (Debt)	0.36	54.98	-148.21	-75.51	-53.85
Net Cash Per Share	0.00	0.64	-1.76	-0.92	-
Filing Date Shares Outstanding	101.46	101.35	84.92	82.18	-
Total Common Shares Outstanding	101.46	101.35	84.92	82.18	-
Working Capital	248.74	254.34	10.47	33.41	41.8
Book Value Per Share	3.62	3.49	1.04	0.99	-
Tangible Book Value	348.48	343.39	72.76	65.69	59.83
Tangible Book Value Per Share	3.43	3.39	0.86	0.80	-
Machinery	58.21	49.41	34.98	24.22	17.05
Leasehold Improvements	80.55	65.73	43.47	20.85	11.87

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.